The peptide, derived from the C-terminal fragment of human growth hormone (amino acids 176-191), targets adipose tissue specifically without the broader metabolic effects associated with full growth hormone therapy
Related Topics Peptide Calculator General-purpose reconstitution and dosing calculator Peptide Reconstitution Guide General bacteriostatic water and syringe handling Where to Inject KLOW Peptide Standard subcutaneous sites and rotation BPC-157 Guide Standalone dosing, pharmacokinetics, oral vs injectable TB-500 / TB-4 Guide Fragment vs full-length, CoA verification, threshold-saturation mechanism GHK-Cu Guide Copper peptide mechanism for skin and matrix quality KPV Guide Anti-inflammatory mechanism, gut and skin applications NAD+ Deep Dive Cellular energy support for intensive repair cycles References GHK-Cu tissue-organization signaling and copper-peptide complex TGF-/Smad matrix organization, lysyl oxidase cross-linking, SOD/catalase antioxidant expression, copper coordination chemistry, 4,000+ gene modulation: PubMed 29986520
You feel fuller for longer and end up eating less
Clinical Trial Dosing Data AOD-9604 has been evaluated across multiple administration routes and dosing regimens
Current evidence suggests Tirzepatide produces the greatest average weight loss
